Data / Form D filings / Federated Biologics Inc.
Federated Biologics Inc.: Form D filings
Federated Biologics Inc., a biotechnology company in Alexandria, Australia, filed 2 Form D notices with the SEC in 2026. The latest, on May 13, 2026, reports $2.5 million sold of a $4.4 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- SHOP 1, 2 RALPH STREET, Alexandria, Australia, NSW 2
- Phone
- (617) 589-3821
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2130284
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | New notice | $4,400,000 | $2,455,000 | $1,945,000 | 4 | May 8, 2026 | sec.gov |
| May 8, 2026 | New notice | $5,999,997 | $5,999,997 | 7 | Apr 28, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Lavner | Director | |
| George Peppou | Executive Officer, Director |
Every Form D from the week of May 11, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Federated Biologics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.